Covered recipient · General Payments record
AMANDA R BONHAM
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$6,702.64
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,085.00 | 1 |
| Travel and Lodging | $1,489.69 | 3 |
| Food and Beverage | $1,009.59 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $3,878.39 | 8 |
| Acerta Pharma LLC | $278.68 | 3 |
| Janssen Biotech, Inc. | $124.55 | 1 |
| SERVIER PHARMACEUTICALS LLC | $110.42 | 1 |
| Exelixis Inc. | $102.56 | 1 |
| Merck Sharp & Dohme Corporation | $53.40 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $36.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $94.21 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105820285 | CMS |
| AstraZeneca Pharmaceuticals LP | $63.94 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105437189 | CMS |
| AstraZeneca Pharmaceuticals LP | $120.53 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105629782 | CMS |
| Exelixis Inc. | $102.56 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138568199 | CMS |
| Janssen Biotech, Inc. | $124.55 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078495110 | CMS |
| Merck Sharp & Dohme LLC | $25.06 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141708288 | CMS |
| Merck Sharp & Dohme LLC | $28.34 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141873641 | CMS |
| Novartis Pharmaceuticals Corporation | $36.28 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086625789 | CMS |
| PFIZER INC. | $124.99 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131474963 | CMS |
| PFIZER INC. | $97.20 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131506520 | CMS |
| PFIZER INC. | $670.26 | 05/20/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1131591545 | CMS |
| PFIZER INC. | $668.78 | 05/20/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1131592529 | CMS |
| PFIZER INC. | $78.53 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131592533 | CMS |
| PFIZER INC. | $2.98 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131699437 | CMS |
| PFIZER INC. | $150.65 | 06/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1132014444 | CMS |
| PFIZER INC. | $2,085.00 | 07/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1132014446 | CMS |
| SERVIER PHARMACEUTICALS LLC | $110.42 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147264986 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.